Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 104

1.

T-bet modulates the antibody response and immune protection during murine malaria.

Oakley MS, Sahu BR, Lotspeich-Cole L, Majam V, Thao Pham P, Sengupta Banerjee A, Kozakai Y, Morris SL, Kumar S.

Eur J Immunol. 2014 Sep;44(9):2680-91. doi: 10.1002/eji.201344437. Epub 2014 Aug 20.

2.

The transcription factor T-bet regulates parasitemia and promotes pathogenesis during Plasmodium berghei ANKA murine malaria.

Oakley MS, Sahu BR, Lotspeich-Cole L, Solanki NR, Majam V, Pham PT, Banerjee R, Kozakai Y, Derrick SC, Kumar S, Morris SL.

J Immunol. 2013 Nov 1;191(9):4699-708. doi: 10.4049/jimmunol.1300396. Epub 2013 Sep 27.

3.

T-bet inhibits the in vivo differentiation of parasite-specific CD4+ Th17 cells in a T cell-intrinsic manner.

Guo S, Cobb D, Smeltz RB.

J Immunol. 2009 May 15;182(10):6179-86. doi: 10.4049/jimmunol.0803821.

4.

Strong impact of CD4+ Foxp3+ regulatory T cells and limited effect of T cell-derived IL-10 on pathogen clearance during Plasmodium yoelii infection.

Abel S, Lückheide N, Westendorf AM, Geffers R, Roers A, Müller W, Sparwasser T, Matuschewski K, Buer J, Hansen W.

J Immunol. 2012 Jun 1;188(11):5467-77. doi: 10.4049/jimmunol.1102223. Epub 2012 Apr 27.

5.

Involvement of CD8+ T cells in protective immunity against murine blood-stage infection with Plasmodium yoelii 17XL strain.

Imai T, Shen J, Chou B, Duan X, Tu L, Tetsutani K, Moriya C, Ishida H, Hamano S, Shimokawa C, Hisaeda H, Himeno K.

Eur J Immunol. 2010 Apr;40(4):1053-61. doi: 10.1002/eji.200939525.

6.

IL-2 contributes to maintaining a balance between CD4+Foxp3+ regulatory T cells and effector CD4+ T cells required for immune control of blood-stage malaria infection.

Berretta F, St-Pierre J, Piccirillo CA, Stevenson MM.

J Immunol. 2011 Apr 15;186(8):4862-71. doi: 10.4049/jimmunol.1003777. Epub 2011 Mar 9.

7.

MAPK phosphotase 5 deficiency contributes to protection against blood-stage Plasmodium yoelii 17XL infection in mice.

Cheng Q, Zhang Q, Xu X, Yin L, Sun L, Lin X, Dong C, Pan W.

J Immunol. 2014 Apr 15;192(8):3686-96. doi: 10.4049/jimmunol.1301863. Epub 2014 Mar 14.

8.

Type I interferons suppress CD4⁺ T-cell-dependent parasite control during blood-stage Plasmodium infection.

Haque A, Best SE, Ammerdorffer A, Desbarrieres L, de Oca MM, Amante FH, de Labastida Rivera F, Hertzog P, Boyle GM, Hill GR, Engwerda CR.

Eur J Immunol. 2011 Sep;41(9):2688-98. doi: 10.1002/eji.201141539. Epub 2011 Aug 8.

9.

Concurrent infection with Heligmosomoides polygyrus suppresses anti-Plasmodium yoelii protection partially by induction of CD4(+)CD25(+)Foxp3(+) Treg in mice.

Tetsutani K, Ishiwata K, Ishida H, Tu L, Torii M, Hamano S, Himeno K, Hisaeda H.

Eur J Immunol. 2009 Oct;39(10):2822-30. doi: 10.1002/eji.200939433.

10.

Generation of human Th1-like regulatory CD4+ T cells by an intrinsic IFN-γ- and T-bet-dependent pathway.

Zheng J, Liu Y, Qin G, Lam KT, Guan J, Xiang Z, Lewis DB, Lau YL, Tu W.

Eur J Immunol. 2011 Jan;41(1):128-39. doi: 10.1002/eji.201040724. Epub 2010 Dec 1.

11.

Differential role of T regulatory and Th17 in Swiss mice infected with Plasmodium berghei ANKA and Plasmodium yoelii.

Keswani T, Bhattacharyya A.

Exp Parasitol. 2014 Jun;141:82-92. doi: 10.1016/j.exppara.2014.03.003. Epub 2014 Mar 24.

PMID:
24675415
12.

Production of interleukin 10 during malaria caused by lethal and nonlethal variants of Plasmodium yoelii yoelii.

Kobayashi F, Morii T, Matsui T, Fujino T, Watanabe Y, Weidanz WP, Tsuji M.

Parasitol Res. 1996;82(5):385-91.

PMID:
8738275
13.

HLA class II (DR0401) molecules induce Foxp3+ regulatory T cell suppression of B cells in Plasmodium yoelii strain 17XNL malaria.

Wijayalath W, Danner R, Kleschenko Y, Majji S, Villasante EF, Richie TL, Brumeanu TD, David CS, Casares S.

Infect Immun. 2014 Jan;82(1):286-97. doi: 10.1128/IAI.00272-13. Epub 2013 Oct 28.

14.

Anti-IL-2 treatment impairs the expansion of T(reg) cell population during acute malaria and enhances the Th1 cell response at the chronic disease.

Zago CA, Bortoluci KR, Sardinha LR, Pretel FD, Castillo-Méndez SI, Freitas do Rosário AP, Hiyane MI, Muxel SM, Rodriguez-Málaga SM, Abrahamsohn IA, Álvarez JM, D'Império Lima MR.

PLoS One. 2012;7(1):e29894. doi: 10.1371/journal.pone.0029894. Epub 2012 Jan 17.

16.

CD4(+) T-cell- and gamma interferon-dependent protection against murine malaria by immunization with linear synthetic peptides from a Plasmodium yoelii 17-kilodalton hepatocyte erythrocyte protein.

Charoenvit Y, Majam VF, Corradin G, Sacci JB Jr, Wang R, Doolan DL, Jones TR, Abot E, Patarroyo ME, Guzman F, Hoffman SL.

Infect Immun. 1999 Nov;67(11):5604-14.

17.

T-bet-independent effects of IL-12 family cytokines on regulation of Th17 responses to experimental T. cruzi infection.

Cobb D, Hambright D, Smeltz RB.

J Leukoc Biol. 2010 Nov;88(5):965-71. doi: 10.1189/jlb.0410238. Epub 2010 Aug 31.

PMID:
20807701
18.

Differential effector pathways regulate memory CD8 T cell immunity against Plasmodium berghei versus P. yoelii sporozoites.

Butler NS, Schmidt NW, Harty JT.

J Immunol. 2010 Mar 1;184(5):2528-38. doi: 10.4049/jimmunol.0903529. Epub 2010 Jan 22.

19.

Age-related susceptibility and resistance to nonlethal Plasmodium yoelii infection in C57BL/6 mice.

Shan Y, Liu J, Jiang YJ, Shang H, Jiang D, Cao YM.

Folia Parasitol (Praha). 2012 Sep;59(3):153-61.

PMID:
23136794
20.

Genetically attenuated parasite vaccines induce contact-dependent CD8+ T cell killing of Plasmodium yoelii liver stage-infected hepatocytes.

Trimnell A, Takagi A, Gupta M, Richie TL, Kappe SH, Wang R.

J Immunol. 2009 Nov 1;183(9):5870-8. doi: 10.4049/jimmunol.0900302. Epub 2009 Oct 7.

Supplemental Content

Support Center